During the past decade, Emerywood Hematology Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emerywood Hematology Oncology" #1 sponsor was "Eisai Inc." with 2 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emerywood Hematology Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Emerywood Hematology Oncology" are "Multiple Myeloma" (2 trials), "Chronic Idiopathic Thrombocytopenic Purpura" (1 trials), "Idiopathic Thrombocytopenic Purpura" (1 trials), "Neurotoxicity" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Emerywood Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Emerywood Hematology Oncology" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "Avatrombopag tablets" (1 trials), "Blinded (Avatrombopoag tablets)" (1 trials), "Blinded (placebo)" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emerywood Hematology Oncology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Emerywood Hematology Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Emerywood Hematology Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emerywood Hematology Oncology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".